Talsupram
Talsupram is a norepinephrine-dopamine reuptake inhibitor (NDRI) that was never marketed. It is structurally related to other NDRIs such as nomifensine and amfonelic acid.
Pharmacology[edit | edit source]
Talsupram acts as a norepinephrine-dopamine reuptake inhibitor (NDRI). It inhibits the reuptake of norepinephrine and dopamine, increasing the levels of these neurotransmitters in the brain. This results in increased neuronal activity and stimulation.
Chemistry[edit | edit source]
Talsupram is structurally related to other NDRIs such as nomifensine and amfonelic acid. It is a synthetic compound and is not found naturally.
History[edit | edit source]
Talsupram was developed in the 1970s but was never marketed. The reasons for this are not clear, but it may be due to potential side effects or lack of efficacy.
See also[edit | edit source]
Talsupram Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD